Related Experiment Video
Updated: Oct 10, 2025
Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
Published on: April 10, 2019
Potential application of biomimetic exosomes in cardiovascular disease: focused on ischemic heart disease
1Department of Internal Medicine, School of Medicine, Ewha Womans University, Seoul 07804, Korea.
Insights
Stem cell-derived exosomes show promise for cardiovascular disease treatment by mediating paracrine effects. Current research focuses on overcoming challenges in exosome isolation, characterization, and delivery for clinical application.
Area of Science:
- Cardiovascular research
- Regenerative medicine
- Biomarker discovery
Background:
- Cardiovascular diseases, particularly ischemic heart disease, are leading causes of global mortality.
- Stem cell therapy offers moderate cardiac repair benefits, primarily through paracrine effects mediated by exosomes.
- Exosomes are crucial for intercellular communication and are emerging as therapeutic agents and biomarkers for cardiovascular conditions.
Approach:
- Reviewing the fundamental role of exosomes in cardiovascular disease.
- Discussing stem cell-derived exosomes and their therapeutic potential.
- Exploring strategies to overcome limitations in exosome clinical application, including engineered biomimetic exosomes.
Key Points:
- Stem cell-derived exosomes are key mediators of therapeutic paracrine effects in cardiovascular repair.
- Exosomes function as cellular cargo, facilitating intercellular communication vital for tissue regeneration.
- Challenges include standardizing exosome isolation/characterization, improving yield, and managing heterogeneity.
Conclusions:
- Exosomes represent a promising therapeutic avenue and biomarker for cardiovascular diseases.
- Overcoming current limitations requires optimized cargo, targeted delivery, and reduced exosome elimination.
- Engineered biomimetic exosomes offer a potential strategy to enhance therapeutic efficacy.
Abstract:
Cardiovascular disease, especially ischemic heart disease, is a major cause of mortality worldwide. Cardiac repair is one of the most promising strategies to address advanced cardiovascular diseases. Despite moderate improvement in heart function via stem cell therapy, there is no evidence of significant improvement in mortality and morbidity beyond standard therapy. The most salutary effect of stem cell therapy are attributed to the paracrine effects and the stem cell-derived exosomes are known as a major contributor. Hence, exosomes are emerging as a promising therapeutic agent and potent biomarkers of cardiovascular disease. Furthermore, they play a role as cellular cargo and facilitate intercellular communication. However, the clinical use of exosomes is hindered by the absence of a standard operating procedures for exosome isolation and characterization, problems related to yield, and heterogeneity. In addition, the successful clinical application of exosomes requires strategies to optimize cargo, improve targeted delivery, and reduce the elimination of exosomes. In this review, we discuss the basic concept of exosomes and stem cell-derived exosomes in cardiovascular disease, and introduce current efforts to overcome the limitations and maximize the benefit of exosomes including engineered biomimetic exosomes. [BMB Reports 2022; 55(1): 30-38].
